# How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

Page: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad
Text version: https://stenobird.com/podcast/cell-gene-the-podcast-4048431/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.md
Podcast: [Cell & Gene: The Podcast](https://stenobird.com/podcast/cell-gene-the-podcast-4048431)
Published: 2026-07-16T09:00:00+00:00
Episode link: https://www.buzzsprout.com/1810482/episodes/19487695-how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.mp3
Audio file: https://www.buzzsprout.com/1810482/episodes/19487695-how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad
Duration seconds: 1083

## Resource

We love to hear from our listeners. Send us a message. Episode 133 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Aprea Therapeutics' CEO, Dr. Oren Gilad. They cover the evolution of precision oncology, the science of synthetic lethality, and how Aprea is developing next-generation therapies that target cancer's unique genetic vulnerabilities while improving safety and efficacy. Dr. Gilad also shares insights into biomarker-driven drug development, where precision ...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/cell-gene-the-podcast-4048431/episodes/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/cell-gene-the-podcast-4048431/how-precision-oncology-is-redefining-cancer-drug-development-with-aprea-therapeutics-dr-oren-gilad.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.